Creating a new bacterial host to discover and produce natural products.
Development of a Bacterial Host for Natural Product Discovery and Production
This study is working on a special type of bacteria to help find and create new medicines from natural sources, which could lead to better treatment options for patients with different health conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Chicago NIH-funded |
| Lab location | 1 site (Chicago, UNITED STATES) |
| Project ID | NIH-10647852 on NIH RePORTER |
What this research studies
This research focuses on developing a specific strain of bacteria, Burkholderia, to enhance the discovery and production of natural compounds that could lead to new medications. By utilizing advanced genome sequencing and synthetic biology techniques, the project aims to overcome challenges such as low yields and the rediscovery of known compounds. Patients may benefit from this research as it could lead to the development of novel drugs derived from natural sources, improving treatment options for various conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with conditions that could be treated by new natural products derived from this research.
Not a fit: Patients who are not seeking new treatment options or those with conditions that do not respond to natural product therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of new natural products that may become effective treatments for diseases.
How similar studies have performed: Other research has shown success in using tailored bacterial hosts for natural product discovery, indicating a promising approach in this field.
Where this research is happening
Chicago, UNITED STATES
- University of Illinois at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Eustaquio, Alessandra S — University of Illinois at Chicago
- Study coordinator: Eustaquio, Alessandra S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.